De Burlo Group’s Core Laboratories CLB Stock Holding History

De Burlo Group’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-25,300	Closed	-$3.04M	–	103
2016 Q4	$3.04M	Buy	+25,300	New	+$2.8M	0.74%	48
2014 Q3	–	Sell	-2,100	Closed	-$351K	–	104
2014 Q2	$351K	Sell	2,100 -43,600	-95%	-$7.76M	0.08%	82
2014 Q1	$9.07M	Buy	45,700 +8,800	+24%	+$1.66M	2.19%	16
2013 Q4	$7.05M	Sell	36,900 -350	-0.9%	-$65.1K	1.68%	22
2013 Q3	$6.3M	Buy	37,250 +3,600	+11%	+$559K	1.72%	20
2013 Q2	$5.1M	Buy	+33,650	New	+$4.77M	1.51%	29

Other funds holding CLB

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

SGA

Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wedgewood Partners St Louis, Missouri $484M AUM 16.04% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

De Burlo Group's CLB Position: Q1 2017 in Review

De Burlo Group sold out of Core Laboratories (CLB) in Q1 2017, closing a stake of 25,300 shares — an estimated $3.04M sold.

De Burlo Group first reported a position in CLB in Q2 2013 and held it in 6 quarters. The position peaked at $9.07M in Q1 2014. 360 funds tracked by Wall St. Rank hold CLB as of Q1 2017.

De Burlo Group reported no remaining Core Laboratories position as of Q1 2017 after selling out during the quarter.
De Burlo Group sold 25,300 Core Laboratories shares in Q1 2017, an estimated $3.04M.
De Burlo Group first reported a position in Core Laboratories in Q2 2013 and held it in 6 quarters.
De Burlo Group's Core Laboratories position peaked at $9.07M in Q1 2014.
360 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2017.

Based on De Burlo Group's 13F filing for Q1 2017, filed 4 May 2017.